To include your compound in the COVID-19 Resource Center, submit it here.

Depletion of the mitochondrial chaperone HspA9 for BRAF-mutant melanoma

DISEASE CATEGORY: Cancer

INDICATION: Melanoma

Reducing production of the mitochondrial chaperone HspA9 could treat BRAF-mutant melanoma. In

Read the full 168 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE